111
Views
0
CrossRef citations to date
0
Altmetric
Stem Cell Transplantation

Early infections in patients undergoing high-dose treatment with stem cell support: a comparison of patients with non-Hodgkin lymphoma and multiple myeloma

, , &
Pages 222-229 | Published online: 18 Jul 2013

References

  • Kolbe K, Domkin D, Derigs HG, Bhakdi S, Huber C, Aulitzky WE. Infectious complications during neutropenia subsequent to peripheral blood stem cell transplantation. Bone Marrow Transplant 1997; 19: 143–147.
  • Slavin MA, Grigg AP, Schwarer AP et al. A randomized comparison of empiric or pre-emptive antibiotic therapy after hematopoietic stem cell transplantation. Bone Marrow Transplant 2007; 40: 157–163.
  • Gil L, Styczynski J, Komarnicki M. Infectious complication in 314patients after high-dose therapy and autologous hematopoietic stem cell transplantation: risk factors analysis and outcome. Infection 2007,35: 421–427.
  • Bodey GP, Buckley M, Sathe YS, Freireich EJ. Quantitative relationships between circulating leukocytes and infection in patients with acute leukaemia. Ann Intern Med 1966; 64: 328–340.
  • de Pauw BE, Derenski SC, Feld R, Lane-Allman EF, Donnelly JP. Ceftazidime compared with piperaccilin and tobramycin for the empiric treatment of fever in neutropenic patients with cancer. A multicenter randomized trial. Ann Intern Med 1994; 120: 834–844.
  • From the Immunocompromised Host Society. The design, analysis, and reporting of clinical trials on the empirical antibiotic management of the neutropenic patient. Report of a consensus panel. J Infect Dis 1990; 161: 397–401.
  • van der Velden WJ, Blijlevens NM, Feuth T, Donnelly JP. Febrilemucositis in haematopoietic SCT recipients. Bone Marrow Transplant 2009; 43: 55–60.
  • Auner HW, Sill H, Mulabecirovic A, Linkesch W, Krause R. Infectious complications after autologous hematopoietic stem cell transplantation: comparison of patients with acute myeloid leukaemia, malignant lymphoma, and multiple myeloma. Ann Hematol 2002; 81: 374–377.
  • Kruger W, Russmann B, Kroger N et al. Early infections in patients undergoing bone marrow or blood stem cell transplanta-tion — a 7 year single centre investigations of 409 cases. Bone Marrow Transplant 1999; 23: 589–597.
  • Engels EA, Ellis CA, Supran SE et al. Early infections in bone marrow transplantation: quantitative study of clinical factors that affect risk. Clin Infect Dis 1999; 28: 256–266.
  • Barton T, Collis T, Stadtmauer E, Schuster M. Infectious complications the year after autologous bone marrow transplanta-tion or peripheral stem cell transplantation for treatment of breast cancer. Clin Infect Dis 2001; 32: 391–395.
  • Saavedra S, Jarque I, Sanz GF et al. Infectious complications in patients undergoing unrelated donor bone marrow transplanta-tion: experience from a single institution. Clin Microbiol Infect 2002; 8: 725–733.
  • Auberger J, Lass-Florl C, Ulmer H et al. Significant alterations in the epidemiology and treatment outcome of invasive fungal infections in patients with hematological malignancies. Int J Hematol 2008; 88: 508–515.
  • Nosari A, Barberis M, Landonio G et al. Infections in haematologic neoplasms: autopsy findings. Haematologica 1991; 76: 135–140.
  • Solano C, Gutierrez A, Martinez F et al. Prophylaxis of early bacterial infections after autologous peripheral blood stem cell transplantation (PBSCT): a matched-pair study comparing oral fluoroquinolones and intravenous piperacillin-tazobactam. Bone Marrow Transplant 2005; 36: 59–65.
  • Offidani M, Corvatta L, Olivieri A et al. Infectious complications after autologous peripheral blood progenitor cell transplantation followed by G-CSF. Bone Marrow Transplant 1999; 24: 1079–1087.
  • Mossad SB, Longworth DL, Goormastic M, Serkey JM, Keys TF, Bolwell BJ. Early infectious complications in autologous bone marrow transplantation: a review of 219 patients. Bone Marrow Transplant 1996; 18: 265–271.
  • Kroschinsky F, Wichmann G, Bornhauser M et al. Efficacy and tolerability of prophylactic treatment with intravenous piperacillin/ tazobactam in patients undergoing hematopoietic stem cell transplantation. Transplant Infect Dis 2002; 4: 132–136.
  • Nosamchuk JD, Sepkowitz KA, Pearse RN, White MH, Nimer SD, Armstrong D. Infectious complications of autologous bone marrow and peripheral stem cell transplantation for refractory leukemia and lymphoma. Bone Marrow Transplant 1996; 18: 355–359
  • Tomas JF, Hernandez LM, Penarrubia MJ et al. Early infections in 103 patients treated with bone marrow transplantation. Sangre (Bare) 1994; 39: 191–196.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.